# Medtronic Completes $650M Acquisition of SPR Therapeutics and Launches ViaVerte PNS System

> ma · REPORTED · 2026-07-16

Medtronic completed its $650 million all-cash acquisition of SPR Therapeutics and formally launched the ViaVerte peripheral nerve stimulation system at the ASPN 2026 conference, expanding its non-opioid, non-surgical pain management portfolio. The SPRINT PNS technology delivers mild electrical stimulation near peripheral nerves to reduce chronic and acute pain.

About Medtronic / SPR Therapeutics: SPR Therapeutics, now part of Medtronic, developed the SPRINT Peripheral Nerve Stimulation System, a temporary percutaneous device that provides non-opioid pain relief by stimulating peripheral nerves, serving patients with chronic and acute pain conditions.

- Company: Medtronic / SPR Therapeutics
- Sector: medical devices
- Primary source: https://finance.yahoo.com/healthcare/articles/medtronic-mdt-completes-650-million-060945862.html

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.